Use access key #2 to skip to page content.
$11.12 -1.11 (-9.08%)
12/1/2008 4:00 PM

Medicis Pharmaceutical Corp (MRX)

CAPS Rating:
****

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

View All Commentary (MRX)

Recs

1

Avatar Richthofen80 (96.20) Submitted: 6/22/08 12:41 PM : Outperform Start Price: $21.09 MRX Score: -9.44

Pure speculation on the Liposonix acquisition. Surgery free fat removal has huge potential if FDA approves. If not, at least they get international exposure because the process is already approved in Europe.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links